These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21150394)

  • 41. Predictors of in-stent stenosis and occlusion after endovascular treatment of intracranial vascular disease with the Willis covered stent.
    Lai XB; Li MH; Tan HQ; Luo BY; Zhu YQ; Wang J; Li YD
    J Clin Neurosci; 2013 Jan; 20(1):122-7. PubMed ID: 23137669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease.
    Derdeyn CP
    Neuroimaging Clin N Am; 2007 Aug; 17(3):303-11, vii-viii. PubMed ID: 17826633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eleven commonly asked questions about ischemic stroke.
    Carnahan L; Block HS; Biller J
    Top Stroke Rehabil; 2013; 20(2):93-100. PubMed ID: 23611849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population attributable risks of stroke from intracranial atherosclerotic disease (ICAD) in South Asian Pakistanis.
    Kamal AK; Wadiwala MF; Ahmed B; Khan M; Majeed F; Rasheed A;
    Int J Stroke; 2013 Jun; 8(4):E17. PubMed ID: 23692491
    [No Abstract]   [Full Text] [Related]  

  • 45. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators.
    Benesch CG; Chimowitz MI
    Neurology; 2000 Aug; 55(4):465-6. PubMed ID: 10953174
    [No Abstract]   [Full Text] [Related]  

  • 46. Current diagnosis and management of symptomatic intracranial atherosclerotic disease.
    Prabhakaran S; Romano JG
    Curr Opin Neurol; 2012 Feb; 25(1):18-26. PubMed ID: 22143202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategic location of large-vessel atherothrombotic cerebral vascular disease.
    Kistler JP
    Arch Neurol; 1999 Nov; 56(11):1329-30. PubMed ID: 10555650
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of atherosclerotic intracranial arterial stenosis.
    Turan TN; Derdeyn CP; Fiorella D; Chimowitz MI
    Stroke; 2009 Jun; 40(6):2257-61. PubMed ID: 19407238
    [No Abstract]   [Full Text] [Related]  

  • 49. Intracranial Stenting Gets a Revisit but Outcomes Still Favor Medical Management.
    Bogason ET; Simon SD; Cockroft KM
    World Neurosurg; 2015 Sep; 84(3):609-11. PubMed ID: 26362066
    [No Abstract]   [Full Text] [Related]  

  • 50. [A stroke of unusual cause].
    Quatre A; Roland G; Benabdelmoumene N; Hovsepian M; Melenotte C; Rossi P; Frances Y; Granel B
    Rev Med Interne; 2014 Mar; 35(3):212-3. PubMed ID: 23849905
    [No Abstract]   [Full Text] [Related]  

  • 51. Association of the metabolic syndrome with intracranial atherosclerotic stroke.
    Ovbiagele B
    Neurology; 2006 Feb; 66(3):459; author reply 459. PubMed ID: 16476966
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter by Reale et al Regarding Article, "Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis".
    Reale G; Giovannini S; Caliandro P
    Stroke; 2019 May; 50(5):e129. PubMed ID: 30890113
    [No Abstract]   [Full Text] [Related]  

  • 53. Intracranial Atherosclerotic Disease.
    Yaghi S; Prabhakaran S; Khatri P; Liebeskind DS
    Stroke; 2019 May; 50(5):1286-1293. PubMed ID: 31009344
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter by Reale et al Regarding Article, "Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease".
    Reale G; Alexandre A; Caliandro P
    Stroke; 2021 Jan; 52(2):e79. PubMed ID: 33493056
    [No Abstract]   [Full Text] [Related]  

  • 55. Response by Lan et al to Letter Regarding Article, "Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease".
    Lan L; Liu H; Leung TW; Leng X
    Stroke; 2021 Jan; 52(2):e80-e81. PubMed ID: 33493054
    [No Abstract]   [Full Text] [Related]  

  • 56. Lipoprotein(a): involved in events, but not burden of atherosclerotic disease?
    Spence JD
    Stroke; 2006 Jun; 37(6):1350-1. PubMed ID: 16675731
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapeutic Strategies for Intracranial Atherosclerosis.
    Anderson CS; Song L; Liu J
    JAMA; 2022 Aug; 328(6):529-531. PubMed ID: 35943482
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of Different Antithrombotic Regimens to Prevent Postoperative Restenosis in Patients With Lower Extremity Arteriosclerosis.
    Gao Z; Qin Y; Yu T; Wang W; Zhu CY; Qiao T; Li XQ; Da L; Ran F
    Am J Ther; 2021 Feb; 28(4):e517-e520. PubMed ID: 33443871
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter by Bos et al Regarding Article, "Intracranial Atherosclerotic Disease: Mechanisms and Therapeutic Implications".
    Bos D; van der Toorn J; Licher S
    Stroke; 2019 Sep; 50(9):e261. PubMed ID: 31288674
    [No Abstract]   [Full Text] [Related]  

  • 60. Response by Yaghi et al to Letter Regarding Article, "Intracranial Atherosclerotic Disease: Mechanisms and Therapeutic Implications".
    Yaghi S; Prabhakaran S; Khatri P; Liebeskind DS
    Stroke; 2019 Sep; 50(9):e262. PubMed ID: 31288670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.